Hi:
Well, as expected, Pfizer will be POCKETING most of the massive tax breaks they just received (as are many of the largest corporations), dividing gains among investors, some bonuses to a few employees and, especially BONUSES for major execs, and the rest...?
They will be CUTTING any further research of ALZHEIMER'S and PARKINSON'S Diseases. HOWEVER, they will continue R & D for chronic osteoporosis and nerve pain caused by diabetes, shingles and spinal cord injury and is an anti-seizure medication for epilepsy patients. Abandoning research into the brain and central nervous system, ohs a problem. Other large companies will, undoubtedly, use their savings in the same manner.
trump said these companies will now have more money to do research and development. He drastically cut the funds and manpower for the CDC and any other government support for organizations doing the requisite R&D needed to complete years of investment and development of a cure.
Pfizer is expected to be among the prime beneficiaries of the corporate tax cut. The measure allows companies to pay a tax rate as low as 8% on foreign earnings they bring home, a big discount from the 21% top rate the law assesses on domestic earnings, itself a big cut from the previous rate of 35%. By some estimates, that could be worth more than $5 billion to Pfizer alone, not counting any gains from the lower tax rate.
Other than that, I have NO opinion!
Well, as expected, Pfizer will be POCKETING most of the massive tax breaks they just received (as are many of the largest corporations), dividing gains among investors, some bonuses to a few employees and, especially BONUSES for major execs, and the rest...?
They will be CUTTING any further research of ALZHEIMER'S and PARKINSON'S Diseases. HOWEVER, they will continue R & D for chronic osteoporosis and nerve pain caused by diabetes, shingles and spinal cord injury and is an anti-seizure medication for epilepsy patients. Abandoning research into the brain and central nervous system, ohs a problem. Other large companies will, undoubtedly, use their savings in the same manner.
trump said these companies will now have more money to do research and development. He drastically cut the funds and manpower for the CDC and any other government support for organizations doing the requisite R&D needed to complete years of investment and development of a cure.
Pfizer is expected to be among the prime beneficiaries of the corporate tax cut. The measure allows companies to pay a tax rate as low as 8% on foreign earnings they bring home, a big discount from the 21% top rate the law assesses on domestic earnings, itself a big cut from the previous rate of 35%. By some estimates, that could be worth more than $5 billion to Pfizer alone, not counting any gains from the lower tax rate.
Other than that, I have NO opinion!
Comments
Post a Comment